Dublin, March 26, 2024 (GLOBE NEWSWIRE) -- The "Antithrombin: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The latest analysis predicts a dynamic expansion of the global Antithrombin market, with forecasts indicating an upsurge from its valuation at US$538.8 Million in 2022 to an anticipated US$809.2 Million by the year 2030. This progression is expected to occur at a compound annual growth rate (CAGR) of 5.2% throughout the period spanning from 2022 to 2030.
Segment Spotlight
Within the market, the Therapeutics segment is presenting a significant growth trajectory, with expectations to achieve a 5.3% CAGR, culminating in a value of US$762.7 Million by 2030. The evolving landscape, influenced by the recovery post-pandemic, sees the Research segment adjusting to a revised 3.4% CAGR over the next eight years.
Regional Market Analysis
The U.S. remains a key player in the Antithrombin market and is forecasted to attain a market size of US$161.7 Million in 2022. Meanwhile, China, seen as the second largest economy globally, is estimated to exhibit a 4.9% CAGR, aiming for a market size of US$142.2 Million by 2030. Other regions, including Japan and Canada, are projected for growth rates of 4.8% and 4.3%, respectively, throughout the 2022-2030 timeframe. Europe's growth forecast is also optimistic, with Germany projected to experience a CAGR of approximately 5%.
Competitive Landscape
The competitive panorama vast, featuring a total of 41 prominent players in the industry. Notable firms in the market have contributed to the industry’s advancement and are expected to continue shaping the market's trajectory during the forecasted period.
Current Global Environment
Current developments such as the implications of the Russia-Ukraine conflict, worldwide inflationary pressures, the easing of China's zero-Covid policy, and its impact on the global market are under scrutiny. Additionally, factors such as supply chain disruptions, escalating global trade tensions, and potential recession risks are being closely monitored for their impacts on the Antithrombin market.
Strategic Market Presence
The market is observed across multiple geographies with versatile levels of presence, from strong, active participations to more niche and trivial engagements.
Continuing Progress and Updates
The sector is committed to continual improvement with online interactive, peer-to-peer collaborative updates, ensuring that stakeholders stay abreast of the latest market developments. With attention to excellence and innovation, the market is set to retain its growth pattern over the coming years, reflecting the dynamic nature of the Antithrombin industry.
This press release has been carefully prepared to provide insightful information about the global Antithrombin market, ensuring a comprehensive understanding of the current market trends and future expectations. The industry's growth prospects highlight its critical role in the medical field, providing valuable therapeutics for a range of conditions.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 194 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $538.8 Million |
| Forecasted Market Value (USD) by 2030 | $809.2 Million |
| Compound Annual Growth Rate | 5.2% |
| Regions Covered | Global |
A selection of companies mentioned in this report includes
- CSL Behring
- Grifols International SA
- Kedrion SpA
- Lee Biosolutions, Inc.
- LFB SA
- Scripps Laboratories
- Shire PLC
For more information about this report visit https://www.researchandmarkets.com/r/6o8oav
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
